Komodo Health Stock
| Valuation | $3.71B1 |
| Valuation Date | Mar 31, 2025 |
| Implied Valuation | $4.37B |
| Last Price | $15.04 |
| 52-Week High | $15.04 |
| 52-Week Low | $12.61 |
| YTD Return | +6.21% |
| 1-Year Return | +9.14% |
| 3-Year Return | -25.29% |
| Total Funding | $585.62M1 |
| Latest Round Amount | $50M1 |
| Latest Round | Series F |
| Funding Rounds | 8 |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | n/a |
| Revenue Type | n/a |
| P/S Ratio | n/a |
About Komodo Health
Komodo Health is a healthcare intelligence company that builds AI-powered analytics software for life sciences and healthcare organizations. Its Healthcare Map tracks more than 330 million de-identified U.S. patient journeys across claims, clinical and other data sources. On top of that map, the company sells Marmot, a healthcare-native AI analytics platform that generates transparent, auditable insights for clinical development, market access, commercialization and real-world evidence. Komodo makes money by licensing its data platform and software subscriptions to pharmaceutical companies, payers, providers and other healthcare stakeholders.
Invest in Komodo Health
Komodo Health is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
News
Komodo Health and NCQA Partner to Modernize HEDIS Measures
Komodo Health announced a multi-year effort with NCQA to modernize healthcare quality measure development, including a new colorectal cancer follow-up HEDIS measure for measurement year 2027.
Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
Komodo Health expanded its partnership with Alnylam Pharmaceuticals to scale Marmot, its analytics AI platform, across key enterprise functions. Alnylam was an early Marmot adopter when the platform l...
Komodo Health Evolves Leadership Structure and Names Miles Ennis President
Komodo appointed Miles Ennis as President and elevated co-founder Web Sun to co-CEO alongside co-founder Arif Nathoo. Ennis previously served as CRO and COO after joining in July 2024.
Komodo Health Appoints Paul Thomas as Chief Financial Officer
Komodo promoted Paul Thomas to CFO after he served as SVP of Finance and Acting CFO since April 2025. Thomas previously led strategic finance roles at Talkdesk and Sumo Logic.
GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset.
Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation
Komodo said it was named to the 2025 Forbes Cloud 100, TIME's World’s Top HealthTech Companies and The Healthcare Technology Report's Top 25 Healthcare Software Companies.
Komodo Health Introduces Marmot, the AI Built to Accelerate Healthcare Innovation
Komodo launched Marmot, a healthcare-native AI analytics engine built on its Healthcare Map of more than 330 million de-identified patient journeys. Alnylam Pharmaceuticals entered an enterprise agree...
Komodo Health Partners With Nasdaq to Deliver First Integrated Healthcare-Specialized Data Insights to the Financial Services Industry
Komodo partnered with Nasdaq Data to power the Nasdaq Medical Claims Insights dataset for hedge funds, private equity and venture firms using de-identified Healthcare Map data.
Komodo Health Is Named to the 2024 Forbes Cloud 100
Komodo said it was named to the Forbes 2024 Cloud 100 ranking of top private cloud companies, published with Bessemer Venture Partners and Salesforce Ventures.
Komodo Health Introduces the First Integrated Patient Insurance Dataset to Enhance Patient-Level Insights for Life Sciences
Komodo announced an integrated patient insurance dataset intended to deepen patient-level insights for life sciences customers on its Healthcare Map platform.
GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine The Company will also participate in a ...
MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
MoonLake Immunotherapeutics inks three-year technology partnership with Komodo Health to advance research on inflammatory skin and joint conditions
MoonLake Immunotherapeutics Inks Three-Year Technology Partnership With Komodo Health To Advance Research on Inflammatory Skin and Joint Conditions
SAN FRANCISCO & ZUG, Switzerland--(BUSINESS WIRE)--MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammat...
Komodo Health, once tipped for a looming IPO, has cut staff as CFO departs
TechCrunch reported Komodo laid off about 9% of staff and closed a roughly $200 million structured equity infusion from Coatue and Dragoneer as IPO plans were delayed.
Chinook Therapeutics, IgA Nephropathy Foundation and Komodo Health Collaborate to Provide Nephrologists with Support and Information to Help Reduce Barriers to Diagnosis and Care
SEATTLE, April 05, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), the IgA Nephropathy Foundation and Komodo Health today announced an outreach initiative leveraging data and techn...
Digital health's top 10 money raisers in 2021—so far
Fierce Healthcare reported Komodo's $220 million Series E led by Tiger Global valued the company at $3.3 billion according to the company.
Komodo Health Secures $220M in Funding Led by Tiger Global
Komodo announced a $220 million Series E led by Tiger Global Management with participation from Casdin Capital, ICONIQ Growth, Andreessen Horowitz and SVB Capital.
Komodo Health Acquires Mavens, Creating the First Data-Driven Enterprise Platform for Life Sciences
Komodo acquired cloud life-sciences software company Mavens and announced a $44 million Series D led by ICONIQ Growth with participation from a16z, Oak HC/FT and others.
OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving Support for Providers and Patients Komodo's Extensive Healthcare Map Powers Precise Care Milestone Mapping, Improving...